NCT00354172 · OUTCOME

Number of Participants (Patients) Who Died by 24 Months

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: Participants
Interval / dispersion: Not reported
Time frame: 2 years post-transplant

What was measured

Number of patients who died after receiving treatment within 24 months post transplant.

Groups in this outcome

Evaluable Patients

All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Evaluable Patients	15

Reported measurements

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Evaluable Patients	15	Not reported	Not reported	Not reported	Not reported

Complete source fields

anticipated Posting Date

2009-11

classes

categories
measurements
group Id
OG000
value
15

denoms

counts
group Id
OG000
value
15
units
Participants

description

Number of patients who died after receiving treatment within 24 months post transplant.

groups

description
All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
id
OG000
title
Evaluable Patients

param Type

NUMBER

reporting Status

POSTED

time Frame

2 years post-transplant

title

Number of Participants (Patients) Who Died by 24 Months

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice